Radiofrequency versus Ethanol Ablation for Single-Session Treatment of Benign Cystic Thyroid Nodules: A Short-Term Retrospective Study
Van Bang Nguyen,Xuan Nguyen Thi,Hau Nguyen Van Vy,Tuyen Linh Pham Nguyen,Thuy Nguyen Hai,Nguyen Dinh Toan,Chi Van Le
DOI: https://doi.org/10.2147/TCRM.S393213
2023-01-25
Therapeutics and Clinical Risk Management
Abstract:Van Bang Nguyen, 1, &ast Xuan Nguyen Thi, 1 Hau Nguyen Van Vy, 1 Tuyen Linh Pham Nguyen, 1 Thuy Nguyen Hai, 2 Nguyen Dinh Toan, 2 Chi Van Le 2, &ast 1 Center of Endocrinology and Diabetes, Family Hospital, Da Nang, Vietnam; 2 Department of Internal Medicine, Hue University of Medicine and Pharmacy, Hue University, Hue City, Vietnam &astThese authors contributed equally to this work Correspondence: Van Bang Nguyen, Center of Endocrinology and Diabetes, Family Hospital, No. 73 Nguyen Huu Tho Str, Da Nang, Vietnam, Tel +84 973445417, Email Chi Van Le, Department of Internal Medicine, Hue University of Medicine and Pharmacy, Hue University, Hue City, Vietnam, Tel +84913426457, Email Objective: This study aims to compare 1-month's efficacy and safety of single-session ethanol ablation and radiofrequency ablation for treating both purely cystic nodules and predominantly cystic thyroid nodules. Materials and methods: This short-term retrospective study was approved by the Ethics Committee of the Institutional Review Board of Danang Family hospital, and written informed consent for procedures was obtained for all patients. Thirty-nine patients who presented with cystic thyroid nodules and met inclusion criteria were extracted from the computerized medical records. The internal fluid of cystic thyroid nodules was aspirated as much as possible. Ethanol ablation was performed using 18-gauge needles with 99.5% ethanol, and RFA used a cooled-electrode RFA system and 18-gauge internally cooled electrodes via the trans-isthmic approach, moving-shot technique. Nodule volume, therapeutic success rate, the largest diameter, thyroid function tests, and complications were evaluated and compared before and after treatment in each group. Results: Among 39 patients, 17 patients were undergone EA (mean age of 47.35 years; the proportion of female of 76.5%; purely thyroid cyst percentage of 41.4%) and 22 patients were undergone RFA (mean age of 46.63 years; the proportion of female of 86.4%; purely thyroid cyst percentage of 54.5%). Both treatment techniques showed a significant reduction of the largest diameter and nodule volume (p< 0.05) without complications. RFA reduced nodule volume and the largest nodule size greater than EA treatment at 1-month post-ablation (p< 0.05). In addition, the therapeutic success rate in the RFA group was higher than in the EA group. Conclusion: Both RFA and EA treatment with single-session confirm the efficacy and safety for cystic thyroid nodules at 1-month follow-up, RFA reduced greater in nodule volume and the largest nodule size than the EA treatment. Thus, the therapeutic success rate in the RFA group was higher than in the EA group. Keywords: radiofrequency ablation, ethanol ablation, cystic thyroid nodules, efficacy and safety Thyroid nodules are the 2nd most common endocrine disorder after diabetes. 1 Among thyroid nodules, partially cystic accounted for 53.5%, with 13.7% described as greater than 75% cystic. 2 The treatment of benign thyroid cystic nodules usually depends on the presence of compressible and/or cosmetic symptoms. Ethanol ablation (EA), as well as radiofrequency ablation (RFA), for cystic thyroid nodules have been proven their efficacy according to nodule characteristics (solid proportion, vascularity, nodule size). However, a more effective technique for thyroid cystic nodule treatment is still debated. For purely cystic thyroid nodules, although RFA showed significantly greater volume reduction during the first 3 months after RFA, the difference seen at 6 months was not significant. Thus, EA has been recommended as the top priority because of its similar efficacy in volume reduction rate with fewer treatment sessions compared to RFA. 3–5 However, for predominantly cystic thyroid nodules (PCTNs), EA shows a less volume reduction rate (VRR) with higher recurrence risk (from 26% to 33%) than RFA 6,7 which is a result of regrowing or bleeding from the vascularity inside and around the solid component in PCTNs. 6,8,9 Controversially, Baek et al conducted a single-blind, randomized trial which showed that the RFA's efficacy in VRR is not superior to that of EA, 87.5 ± 11.5% for RFA and 82.4 ± 28.6% for EA. 10 To the best of our knowledge, there is no study comparing the efficacy of 2 techniques in single-session treatment in both purely cystic nodules and PCTNs in short-term follow-up in Vietnam. Therefore, the purpose of this study was to compare 1 month's efficacy and safety of single-session EA and RFA for treating both purely cystic nodules and PCTNs. This study was conducted in accordance with -Abstract Truncated-
health care sciences & services